Axel Pähler Selected Research

Axel Pähler Research Topics

2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 06/2006
2	Mental Disorders (Mental Disorder) 02/2016 - 02/2015
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Serotonin Syndrome (Syndrome, Serotonin) 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Amyloid Plaque 01/2017
1	Gliosis 01/2017
1	Chemical and Drug Induced Liver Injury 11/2015
1	Fragile X Syndrome (Martin Bell Syndrome) 02/2015
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 02/2015
1	Parkinson Disease (Parkinson's Disease) 02/2015
1	Dyskinesias (Dyskinesia) 02/2015
1	Type 2 Diabetes Mellitus (MODY) 04/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2012
1	Dyslipidemias (Dyslipidemia) 07/2012
1	Drug-Related Side Effects and Adverse Reactions 04/2008
1	Cholestasis 08/2006
1	Disease Progression 06/2006

3	Pharmaceutical PreparationsIBA 02/2016 - 08/2006
1	Monoamine Oxidase (MAO)IBA 01/2017
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2017
1	Antidepressive Agents (Antidepressants)IBA 01/2017
1	sembragilineIBA 01/2017
1	TyramineIBA 01/2017
1	Serotonin (5 Hydroxytryptamine)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2015
1	2- chloro- 4- (1- (4- fluorophenyl)- 2,5- dimethyl- 1H- imidazol- 4- ylethynyl)pyridineIBA 02/2015
1	pyridineIBA 02/2015
1	antineoplaston A10 (A 10)IBA 02/2015
1	Diazepam (Valium)FDA LinkGeneric 02/2015
1	Levodopa (L Dopa)FDA LinkGeneric 02/2015
1	Metabotropic Glutamate 5 ReceptorIBA 02/2015
1	Glucose (Dextrose)FDA LinkGeneric 04/2014
1	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2014
1	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 04/2014
1	Cholesterol Ester Transfer ProteinsIBA 07/2012
1	dalcetrapibIBA 07/2012
1	Glutathione (Reduced Glutathione)IBA 06/2006
1	Biomarkers (Surrogate Marker)IBA 06/2006
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 06/2006